Endologix LLC’s Post

Read full paper in #Med

Discover clinical insights as physicians discuss the new dual-size cryoballoon catheter POLARx™ FIT. Dive into the perspectives shared by physicians in the FROzEN AF trial in this video. https://bit.ly/41UoQWK Safety info: https://bit.ly/48QAVON

Check out our latest blog here : https://shorturl.at/vS138 in which we discuss about our brand's footprints in medical diagnostics industry. #ManipalTRUtest #branddiscussion #latestblog #medical #diagnostic

The official release of Steroids and Me - the first and only digital companion for steroid-treated patients - will commence in one hour. Save your spot to be part of this exciting moment in clinical history: https://hubs.li/Q02CK9kg0 #SteroidsandMe #SteroidToxicity #PatientEducation #PatientOutcomes #PatientAdvocacy #HealthOutcomes

From groundbreaking clinical trials to gaining critical regulatory approvals, 2023 was another landmark year in the field of focused ultrasound. Momentous news for the essential tremor (ET) patient community was the Foundation’s third “most clicked” news story of 2023: # 3: INSIGHTEC announced that the FDA cleared its focused ultrasound device to treat ET patients’ non-dominant side. The disease commonly affects both sides of the body, and up until this news, focused ultrasound was only approved for unilateral treatments. The ruling was based on data that showed a significant reduction in tremor following treatment of the second side. Read: https://ow.ly/qH2I50QpFTW #FocusedUltrasound #EssentialTremor #HealthcareAdvancements #MedicalTechnology #RegulatoryApprovals

❤️ ZOLL Medical Corporation recruits first patient in SSO2 therapy trial in LAD STEMI heart attacks The study is named as SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE). It aims to demonstrate the efficacy of SSO2 Therapy in lowering heart failure and mortality in patients with LAD STEMI. The SSCORE study will also gather data on potential healthcare cost savings from preventing heart failure, compared to long-term palliative treatments. The first patient in the trial was enrolled at the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, a partner of Allina Health. 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Wondering about the role of the iTind™ procedure in the treatment of benign prostatic hyperplasia (BPH)? Dr. Hollowell dives into the details in this on-demand #webinar. Hear more about its benefits, risks, and how it can become an option for your #BPH patients. #iTind

Learn from a real world clinical experience to understand: - How the iTind™ procedure can fit into your BPH treatment options - Who are ideal patients for the iTind™ procedure - Who are not ideal patients for the iTind™ procedure - How to talk to patients about new technology

The official release of Sam - the first and only digital companion for steroid-treated patients - will commence in one hour. Save your spot to be part of this exciting moment in clinical history: https://hubs.li/Q02CJZ990 #SteroidsandMe #SteroidToxicity #PatientEducation #PatientOutcomes #PatientAdvocacy #HealthOutcomes

📢 Don't miss this thought-provoking webinar on Encephalitis! bioMérieux Clinical Diagnostics (IVD) & Encephalitis International have worked to produce an engaging virtual event, aiming to bridge the gap between patient experiences and medical expertise. 💡 Navigating Encephalitis: Insights from Patient and Clinician Perspectives 📆 20th of February 2024 ⌚ 1-2 pm GMT #WED #WorldEncephalitisDay